New Vaccine To Fight Ebola Epidemic Is Approved In The Democratic Republic Of Congo - The Organization for World Peace
The Health Authority of the Democratic Republic of Congo (DRC) said in the past week that it will allow a new vaccine that is developed by drugs company Johnson & Johnson to be used to contain the second ever largest outbreak of Ebola. The current vaccine in use, developed by Merck, is in limited supply, with only 500,000 units remaining; the BBC reports that it is therefore only being given to those who might have come in direct contact with someone known to have Ebola, and to health workers in the field. The new vaccine caused controversy, with former Health Minister Oly Ilunga questioning its effectiveness, in July of this year. He later resigned after having his control over the prevention of Ebola stripped from him.
The current health response team of the DRC government made a statement to Reuters, pointing out that "it is a vaccine that other countries already use. Why can't we use it in Congo to protect our population?" Professor Peter Piot, an expert of Ebola, and Director of the London School of Hygiene and Tropical Medicine, said the new vaccine "has shown outstanding safety" and called for its deployment. The World Health Organisation also has asked for an increase in Ebola prevention, in August calling on states and NGOs to "increase their presence in the field to stop Ebola and to address one of the largest and most complex humanitarian crises in the world".
The new vaccine cannot come soon enough to the DRC. With Ebola being such an infectious disease, containing it has to be the absolute priority, and the Johnson & Johnson drug can do just that. Over 180,000 people have been vaccinated in the twelve months since the outbreak began, but the rate of new cases per week is increasing, with 40 reported cases the week before 17 September 2019, and 57 the following week. Whilst the Merck drug is highly effective, with a 97.5% success rate, there simply is not enough of it reach the herd immunization necessary to end the epidemic.
Johnson and Johnson claim to have 1.5 million vaccines ready for immediate deployment. Over 2100 people in the country have already died from Ebola just in this current epidemic, with a total of 3000 reported cases. There are currently 10 million people in the two most at-risk provinces in North-Eastern DRC. The current plan is therefore to create a large-scale ring of immunized people around the most exposed areas, to function as a buffer of immunized people and contain the epidemic. This plan could only go ahead with enough vaccines available, however. There has also been a tightening of the North-Eastern border with Rwanda, but with more vaccinations, there could be greater effectiveness and more travel allowed.
Looking forward, accompanying the introduction of the Johnson & Johnson drug needs to be an increase of education and trust between outside health workers, drug companies and local populations. The Lancet medical journal reports that 36% of DRC residents thought that Ebola was a hoax designed to "destabilize the country", with the population still mistrusting authority, following the Great African War earlier this century. Al Jazeera has reported multiple attacks on health centres, one of which ended in the death of a health worker. Not only is this tragic, but it leads to less effective treatment for a lethal disease, as vaccinations cannot be administered, and cases cannot be reported. To improve health outcomes, there must be more vaccines, education, and trust.
The Hong Kong clash comes after prominent local activists, including protest leader Joshua Wong, testified in Washington this week in support of human rights legislation. Good morning and welcome to While You Were Sleeping, a quick
Police in the Democratic Republic of Congo have arrested a former health minister for allegedly mismanaging funds allocated for the Ebola epidemic. Oly Ilunga resigned as health minister in July after being stripped
Ebola virus disease (EVD) transmission in the Democratic Republic of the Congo continued to ease this past week, with 40 new confirmed cases reported in North Kivu and Ituri provinces; this is the
When I walked by an Ebola remedy centre in North Kivu Province within the Democratic Republic of the Congo (DRC), 12-year previous Mumbere Kalegha pressed a paper to the glass that separated us and
Published on 11.09.2019 at 17h21 by APA News Rwandan Police on Wednesday seized over 30kg of cannabis at the border with the Democratic Republic of Congo (DRC) and arrested a woman
A British doctor who has helped fight Ebola in the Democratic Republic of Congo says an experimental vaccine 'has changed the path of the outbreak'. Dr Catherine Houlihan, from Aberdeen, returned home to the UK from
More than four decades since it was discovered, Ebola is no less terrifying for adults and children today than it was when the "haemorrhagic fever" was first identified in a village in the Democratic Republic
More News in Health
Following up measles cases and close contacts to contain the spread of the disease, and maintaining the national Childhood Immunisation Schedule, continue to be the priority for Bay of Plenty and Lakes health authorities. A
Media Credit: Hatchet File Photo by Alexander Welling | Assistant Photo Editor Researchers at the School of Medicine and Health Sciences released a study with a list of common bacteria found in a healthy
Following is a summary of current health news briefs. Congo to deploy second Ebola vaccine Health authorities in the Democratic Republic of Congo said on Saturday that they plan to introduce a second Ebola vaccine,
Incurable and increasingly prevalent, dementia is a disease that today affects about 50 million people worldwide. Millions more are diagnosed each year with the most common neurodegenerative form: Alzheimer's disease. The risks generally increase with
Australia has one of the highest rates of bowel cancer in the world, though the United States is high as well. In 2017, bowel cancer was the second-most-common cancer in Australia
Envestnet Asset Management Inc. bought a new stake in shares of Direxion Daily Healthcare Bull 3x Shares (NYSEARCA:CURE) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).